Data / Drug companies / Injection, solution, concentrate
Companies that list injection, solution, concentrate products: 93 companies and 245 products in the FDA NDC directory
The FDA National Drug Code Directory lists 245 products that are injection, solution, concentrate products from 93 companies. The ten largest listers hold 40.4% of them, and the newest started marketing on October 30, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 93
- Products
- 245
- Drugs by generic name
- 61
- Main marketing category
- Generic drugs (ANDA)
Companies that list injection, solution, concentrate products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hospira, Inc. | 31 | injection, solution, concentrate | New drug applications (NDA) | September 29, 2025 |
| Teva Parenteral Medicines, Inc. | 13 | injection, solution, concentrate | Generic drugs (ANDA) | August 15, 2024 |
| Fresenius Kabi USA, LLC | 9 | injection, solution, concentrate | Generic drugs (ANDA) | March 13, 2025 |
| Meitheal Pharmaceuticals Inc. | 9 | injection, solution, concentrate | Generic drugs (ANDA) | June 1, 2025 |
| Fresenius Kabi USA, LLC | 8 | injection, solution, concentrate | New drug applications (NDA) | November 27, 2024 |
| Henry Schein, Inc. | 7 | injection, solution, concentrate | New drug applications (NDA) | February 18, 2022 |
| Mylan Institutional LLC | 7 | injection, solution, concentrate | Generic drugs (ANDA) | October 5, 2020 |
| HF Acquisition Co LLC, DBA HealthFirst | 6 | injection, solution, concentrate | Generic drugs (ANDA) | October 18, 2019 |
| Genentech, Inc. | 5 | injection, solution, concentrate | Biologics (BLA) | November 1, 2013 |
| BioMarin Pharmaceutical Inc. | 4 | injection, solution, concentrate | Drugs for further processing | November 19, 2021 |
| BluePoint Laboratories | 4 | injection, solution, concentrate | Generic drugs (ANDA) | December 1, 2025 |
| Glenmark Pharmaceuticals Inc., USA | 4 | injection, solution, concentrate | Generic drugs (ANDA) | March 12, 2026 |
| Janssen Biotech, Inc. | 4 | injection, solution, concentrate | Biologics (BLA) | April 29, 2025 |
| Milla Pharmaceuticals Inc. | 4 | injection, solution, concentrate | Generic drugs (ANDA) | January 17, 2025 |
| Sandoz Inc | 4 | injection, solution, concentrate | New drug applications (NDA) | April 8, 2024 |
| Somerset Therapeutics, LLC | 4 | injection, solution, concentrate | Generic drugs (ANDA) | August 29, 2019 |
| Amneal Pharmaceuticals Private Limited | 3 | injection, solution, concentrate | Generic drugs (ANDA) | March 3, 2026 |
| Bpi Labs LLC | 3 | injection, solution, concentrate | Generic drugs (ANDA) | June 5, 2025 |
| Camber Pharmaceuticals, Inc. | 3 | injection, solution, concentrate | Generic drugs (ANDA) | January 31, 2025 |
| Caplin Steriles Limited | 3 | injection, solution, concentrate | Generic drugs (ANDA) | September 17, 2026 |
| Chugai Pharmaceutical Co., Ltd. | 3 | injection, solution, concentrate | Drugs for further processing | January 8, 2010 |
| Civica, Inc. | 3 | injection, solution, concentrate | New drug applications (NDA) | March 13, 2025 |
| Eugia US LLC | 3 | injection, solution, concentrate | Generic drugs (ANDA) | September 26, 2016 |
| Gland Pharma Limited | 3 | injection, solution, concentrate | Generic drugs (ANDA) | June 3, 2025 |
| Hikma Pharmaceuticals USA Inc. | 3 | injection, solution, concentrate | Generic drugs (ANDA) | January 14, 2021 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 3 | injection, solution, concentrate | Generic drugs (ANDA) | August 9, 2017 |
| Medical Purchasing Solutions, LLC | 3 | injection, solution, concentrate | New drug applications (NDA) | August 8, 2014 |
| Patheon Italia S.p.A. | 3 | injection, solution, concentrate | Drugs for further processing | September 4, 2026 |
| Sanofi-Aventis U.S. LLC | 3 | injection, solution, concentrate | Authorized generics (NDA) | October 23, 2016 |
| Accord Healthcare Inc. | 2 | injection, solution, concentrate | New drug applications (NDA) | May 17, 2018 |
| Actavis Pharma, Inc. | 2 | injection, solution, concentrate | New drug applications (NDA) | September 1, 2014 |
| Avenacy, LLC | 2 | injection, solution, concentrate | Generic drugs (ANDA) | January 15, 2025 |
| Bamboo US Bidco LCC | 2 | injection, solution, concentrate | Drugs for further processing | December 1, 2020 |
| Baxter Healthcare Corporation | 2 | injection, solution, concentrate | Generic drugs (ANDA) | August 6, 2026 |
| Baxter Healthcare Corporation | 2 | injection, solution, concentrate | New drug applications (NDA) | March 30, 2026 |
| BeOne Medicines USA, Inc. | 2 | injection, solution, concentrate | Biologics (BLA) | July 13, 2026 |
| Chiesi USA, Inc. | 2 | injection, solution, concentrate | Biologics (BLA) | May 23, 2023 |
| Dr. Reddy's Laboratories Inc. | 2 | injection, solution, concentrate | Generic drugs (ANDA) | August 21, 2023 |
| Genzyme Corporation | 2 | injection, solution, concentrate | Biologics (BLA) | November 18, 2014 |
| Hospira, Inc. | 2 | injection, solution, concentrate | Generic drugs (ANDA) | August 10, 2009 |
| Navinta LLC | 2 | injection, solution, concentrate | Generic drugs (ANDA) | December 6, 2025 |
| NorthStar RxLLC | 2 | injection, solution, concentrate | Generic drugs (ANDA) | October 30, 2026 |
| Novadoz Pharmaceuticals LLC | 2 | injection, solution, concentrate | Generic drugs (ANDA) | December 11, 2025 |
| Omnivium Pharmaceuticals LLC. | 2 | injection, solution, concentrate | Generic drugs (ANDA) | May 15, 2025 |
| Patheon Manufacturing Services LLC | 2 | injection, solution, concentrate | Drugs for further processing | May 31, 2022 |
| ProPharma Distribution | 2 | injection, solution, concentrate | New drug applications (NDA) | August 8, 2014 |
| Sanofi-Aventis U.S. LLC | 2 | injection, solution, concentrate | Biologics (BLA) | March 2, 2020 |
| WG Critical Care, LLC | 2 | injection, solution, concentrate | New drug applications (NDA) | April 19, 2016 |
| A-S Medication Solutions | 1 | injection, solution, concentrate | New drug applications (NDA) | August 8, 2014 |
| Ailex Pharmaceuticals, LLC | 1 | injection, solution, concentrate | Generic drugs (ANDA) | February 24, 2016 |
| Alexion Pharmaceuticals Inc. | 1 | injection, solution, concentrate | Biologics (BLA) | April 2, 2007 |
| American Regent, Inc. | 1 | injection, solution, concentrate | Other unapproved drugs | December 9, 1993 |
| Amgen, Inc | 1 | injection, solution, concentrate | Biologics (BLA) | March 1, 2025 |
| Amneal Pharmaceuticals LLC | 1 | injection, solution, concentrate | Generic drugs (ANDA) | June 2, 2026 |
| Anthea Pharma Private Limited | 1 | injection, solution, concentrate | Generic drugs (ANDA) | November 25, 2025 |
| Apotex Corp. | 1 | injection, solution, concentrate | New drug applications (NDA) | June 30, 2026 |
| Aryeh Pharma Corp | 1 | injection, solution, concentrate | Generic drugs (ANDA) | April 10, 2026 |
| B. Braun Medical Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | May 2, 2022 |
| BioConnection B.V. | 1 | injection, solution, concentrate | Drugs for further processing | March 3, 2025 |
| BioMarin International Limited | 1 | injection, solution, concentrate | Drugs for further processing | February 14, 2014 |
| Biocon Pharma Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | July 1, 2025 |
| Breckenridge Pharmaceutical, Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | July 1, 2021 |
| Bryant Ranch Prepack | 1 | injection, solution, concentrate | Generic drugs (ANDA) | November 15, 2022 |
| Dr. Reddy's Laboratories Limited | 1 | injection, solution, concentrate | Generic drugs (ANDA) | March 4, 2013 |
| Emd Serono, Inc. | 1 | injection, solution, concentrate | Biologics (BLA) | March 23, 2017 |
| Hainan Poly Pharm. Co., Ltd. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | August 13, 2024 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | August 31, 2023 |
| Hospira, Inc. | 1 | injection, solution, concentrate | Drugs for further processing | October 1, 2016 |
| Icu Medical Inc. | 1 | injection, solution, concentrate | New drug applications (NDA) | November 20, 2019 |
| Immunocore Commercial LLC | 1 | injection, solution, concentrate | Biologics (BLA) | January 26, 2022 |
| MacroGenics, Inc | 1 | injection, solution, concentrate | Biologics (BLA) | January 15, 2021 |
| Maia Pharmaceuticals, Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | May 22, 2017 |
| Novartis Pharma Stein AG | 1 | injection, solution, concentrate | Drugs for further processing | March 14, 2024 |
| Novartis Pharmaceuticals Corporation | 1 | injection, solution, concentrate | Biologics (BLA) | October 6, 2023 |
| Omeros Corporation | 1 | injection, solution, concentrate | New drug applications (NDA) | June 13, 2014 |
| Par Health USA, LLC | 1 | injection, solution, concentrate | Generic drugs (ANDA) | August 19, 2014 |
| Precision Dose, Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | October 10, 2024 |
| Rayner Surgical Inc. | 1 | injection, solution, concentrate | New drug applications (NDA) | July 1, 2023 |
| Recordati Rare Diseases, Inc. | 1 | injection, solution, concentrate | Biologics (BLA) | February 4, 2022 |
| Regeneron Pharmaceuticals, Inc. | 1 | injection, solution, concentrate | Biologics (BLA) | August 19, 2026 |
| Remedyrepack Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | February 3, 2025 |
| Sagent Pharmaceuticals | 1 | injection, solution, concentrate | Generic drugs (ANDA) | May 15, 2017 |
| Sanofi-Aventis Deutschland GmbH | 1 | injection, solution, concentrate | Drugs for further processing | July 9, 2026 |
| Siga Technologies, Inc. | 1 | injection, solution, concentrate | New drug applications (NDA) | May 31, 2022 |
| Slate Run Pharmaceuticals, LLC | 1 | injection, solution, concentrate | Generic drugs (ANDA) | October 15, 2020 |
| TG Therapeutics, Inc. | 1 | injection, solution, concentrate | Biologics (BLA) | December 28, 2022 |
| Tagi Pharma, Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | November 30, 2018 |
| TerSera Therapeutics LLC | 1 | injection, solution, concentrate | Biologics (BLA) | January 15, 2021 |
| Teva Respiratory, LLC | 1 | injection, solution, concentrate | Biologics (BLA) | April 18, 2016 |
| Ucb, Inc. | 1 | injection, solution, concentrate | New drug applications (NDA) | August 23, 2006 |
| XGen Pharmaceuticals DJB, Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | August 5, 2011 |
| Zydus Pharmaceuticals USA Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | February 8, 2021 |
| Zydus Pharmaceuticals USA Inc. | 1 | injection, solution, concentrate | Generic drugs (ANDA) | September 19, 2023 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Levetiracetam | 9 | 87 |
| Potassium chloride | 10 | 84 |
| Sodium chloride | 7 | 71 |
| Sulfamethoxazole and trimethoprim | 9 | 48 |
| Levofloxacin | 2 | 42 |
| Epinephrine | 13 | 32 |
| Norepinephrine bitartrate | 12 | 25 |
| Cyclophosphamide | 3 | 22 |
| Docetaxel | 14 | 21 |
| Dexmedetomidine hydrochloride | 4 | 21 |
| Paclitaxel | 7 | 20 |
| Zoledronic acid | 14 | 18 |
| Oxaliplatin | 4 | 16 |
| Sodium nitroprusside | 5 | 14 |
| Dextrose monohydrate | 1 | 12 |
| Dexmedetomidine | 4 | 11 |
| Ketamine hydrochloride | 3 | 11 |
| Dopamine hydrochloride | 6 | 10 |
| Etoposide | 6 | 9 |
| Pemetrexed | 6 | 9 |
| Busulfan | 1 | 8 |
| Sodium phenylacetate and sodium benzoate | 8 | 7 |
| Potassium phosphates | 7 | 6 |
| Sodium acetate | 10 | 5 |
| Romidepsin | 1 | 5 |
| Dobutamine | 3 | 4 |
| Tocilizumab | 3 | 4 |
| Potassium acetate | 6 | 3 |
| Potassium phosphate, monobasic potassium phosphate, dibasic | 4 | 3 |
| Alprostadil | 1 | 3 |
| Topotecan | 1 | 3 |
| Mitoxantrone | 3 | 2 |
| Margetuximab-cmkb | 2 | 2 |
| Phenylephrine and ketorolac | 2 | 2 |
| Trabectedin | 1 | 2 |
| Tocilizumab-aazg | 3 | 1 |
| Daratumumab | 2 | 1 |
| Dopamine hci | 2 | 1 |
| Isatuximab | 2 | 1 |
| Nipocalimab-aahu | 2 | 1 |
| Pegunigalsidase alfa | 2 | 1 |
| Tislelizumab-jsgr | 2 | 1 |
| Alemtuzumab | 1 | 1 |
| Avelumab | 1 | 1 |
| Eculizumab | 1 | 1 |
| Eculizumab-aeeb | 1 | 1 |
| Elosulfase alfa | 1 | 1 |
| Garetosmab-grts | 1 | 1 |
| Laronidase | 1 | 1 |
| Levophed(r) norepinephrine bitartrate | 1 | 1 |
| Obinutuzumab | 1 | 1 |
| Pertuzumab | 1 | 1 |
| Reslizumab | 1 | 1 |
| Secukinumab | 1 | 1 |
| Sodium acetate injection, usp, 200 meq/100 ml | 1 | 1 |
| Sodium acetate injection, usp, 400 meq/100 ml | 1 | 1 |
| Sutimlimab-jome | 1 | 1 |
| Tebentafusp | 1 | 1 |
| Tecovirimat monohydrate | 1 | 1 |
| Trace elements 4 | 1 | 1 |
| Ublituximab | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.